NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizu...
Buyer
NHS England
Value
£986,282,758
Published
29 Jul 2025
Closes
7 Apr 2025
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
31 Aug 2025
Contract ends
31 Aug 2027
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
£4,108,145,000
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
29 Jul 2025
Awarded contract notice on Contracts Finder
Award notice · Web page
Framework Agreement and Terms and Conditions - Tranche B - 1 September 2025
Not provided
Framework Agreement and Terms and Conditions - Tranche B - 1 September 2025
Tranche B -Transparency Award Schedules - CM_PHR_24_5680_01
Not provided
Tranche B -Transparency Award Schedules - CM_PHR_24_5680_01
Tranche B -Transparency Award Schedules - CM_PHR_24_5680_02
Not provided
Tranche B -Transparency Award Schedules - CM_PHR_24_5680_02
Contains public sector information licensed under the Open Government Licence v3.0.